Differential expression of E prostanoid receptors in murine and human non-melanoma skin cancer

Journal of Investigative Dermatology

Volumn 125, Issue 4, 2005, Pages 818-825

  Lee, Juliette Lois ^a   Kim, Arianna ^a   Kopelovich, Levy ^b   Bickers, David R ^a   Athar, Mohammad ^a  

^a Columbia University ^*  (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Basal cell carcinoma; Cyclooxygenase; Non melanoma skin cancer; Prostaglandin E2 (PGE2); Squamous cell carcinoma

Indexed keywords

E PROSTANOID 1 RECEPTOR; E PROSTANOID 2 RECEPTOR; E PROSTANOID 3 RECEPTOR; E PROSTANOID 4 RECEPTOR; MESSENGER RNA; PROSTAGLANDIN E RECEPTOR; PROSTANOID RECEPTOR; UNCLASSIFIED DRUG; CYCLIC AMP; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; EP4 RECEPTOR; MEMBRANE PROTEIN; PROSTAGLANDIN EP2 RECEPTOR; PROSTAGLANDIN EP3 RECEPTOR; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID RECEPTOR EP1; PTGS2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ANALYSIS; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; ULTRAVIOLET B RADIATION; ANIMAL; CHEMISTRY; GENETICS; HAIRLESS MOUSE; IMMUNOHISTOCHEMISTRY; PAPILLOMA; SKIN TUMOR;

ANIMALS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CYCLIC AMP; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; MICE, INBRED HRS; PAPILLOMA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER; SKIN NEOPLASMS;

EID: 27744479679     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23829.x     Document Type: Article

References (34)

1. An KP, Athar M, Tang X, et al: Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: Implications for therapeutic approaches. Photochem Photobiol 76:73-80, 2002
2. Aszterbaum M, Epstein J, Oro A, Douglas V, LeBoit PE, Scott MP, Epstein EH Jr: Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med 5:1285-1291, 1999
3. Athar M, An KP, Morel KD, et al: Ultraviolet B (UVB)-induced cox-2 expression in murine skin: An immunohistochemical study. Biochem Biophys Res Commun 280:1042-1047, 2001
4. Athar M, Li C, Tang X, et al: Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Cancer Res 64:7545-7552, 2004
5. Bonifas JM, Pennypacker S, Chuang PT, et al: Activation of expression of hedgehog target genes in basal cell carcinomas. J Invest Dermatol 116:739-742, 2001
6. Buckman SY, Gresham A, Hale P, Hruza G, Anast J, Masferrer J, Pentland AP: COX-2 expression is induced by UVB exposure in human skin: Implications for the development of skin cancer. Carcinogenesis 19:723-729, 1998
7. Chang SH, Liu CH, Conway R, et al: Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc Natl Acad Sci USA 101:591-596, 2004
8. Chun KS, Kim SH, Song YS, Surh YJ: Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Carcinogenesis 25:713-722, 2004
9. Dannenberg AJ, Altorki NK, Boyle JO, Dang C, Howe LR, Weksler BB, Subbaramaiah K: Cyclo-oxygenase 2: A pharmacological target for the prevention of cancer. Lancet Oncol 2:544-551, 2001
10. Desai S, April H, Nwaneshiudu C, Ashby B: Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: Role of the carboxyl terminus in EP4 receptor sequestration. Mol Pharmacol 58:1279-1286, 2000
11. Desai S, Ashby B: Agonist-induced internalization and mitogen-activated protein kinase activation of the human prostaglandin EP4 receptor. FEBS Lett 501:156-160, 2001
12. Fischer SM, Lo HH, Gordon GB, Seibert K, Kelloff G, Lubet RA, Conti CJ: Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog 25:231-240, 1999
13. Gailani MR, Stahle-Backdahl M, Leffell DJ, et al: The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 14:78-81, 1996
14. Harris RE, Beebe-Donk J, Schuller HM: Chemoprevention of lung cancer by nonsteroidal anti-inflammatory drugs among cigarette smokers. Oncol Rep 9:693-695, 2002
15. Harris RE, Kasbari S, Farrar WB: Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep 6:71-73, 1999
16. Hasegawa H, Katoh H, Fujita H, Mori K, Negishi M: Receptor isoform-specific interaction of prostaglandin EP3 receptor with muskelin. Biochem Biophys Res Commun 276:350-354, 2000a
17. Hasegawa H, Katoh H, Yamaguchi Y, Nakamura K, Futakawa S, Negishi M: Different membrane targeting of prostaglandin EP3 receptor isoforms dependent on their carboxy-terminal tail structures. FEBS Lett 473:76-80, 2000b
18. Lee JL, Mukhtar H, Bickers DR, Kopelovich L, Athar M: Cyclooxygenases in the skin: Pharmacological and toxicological implications. Toxicol Appl Pharmacol 192:294-306, 2003
19. Marks R: An overview of skin cancers. Incidence and causation. Cancer 75:607-612, 1995
20. Marnett LJ, Rowlinson SW, Goodwin DC, Kalgutkar AS, Lanzo CA: Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition. J Biol Chem 274:22903-22906, 1999
21. Muller-Decker K, Neufang G, Berger I, Neumann M, Marks F, Furstenberger G: Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc Natl Acad Sci USA 99:12483-12488, 2002
22. Narumiya S, Sugimoto Y, Ushikubi F: Prostanoid receptors: Structures, properties, and functions. Physiol Rev 79:1193-1226, 1999
23. Neufang G, Furstenberger G, Heidt M, Marks F, Muller-Decker K: Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin. Proc Natl Acad Sci USA 98:7629-7634, 2001
24. Pentland AP, Schoggins JW, Scott GA, Khan KN, Han R: Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 20:1939-1944, 1999
25. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res e45: 2002-2007, 2001
26. Sales KJ, Katz AA, Davis M, et al: Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: A possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. J Clin Endocrinol Metab 86:2243-2249, 2001
27. Schapira DV, Theodossiou C, Lyman GH: The effects of NSAIDs on breast cancer prognostic factors. Oncol Rep 6:433-435, 1999
28. Schmittgen TD, Zakrajsek BA: Effect of experimental treatment on housekeeping gene expression: Validation by real-time, quantitative RT-PCR. J Biochem Biophys Methods 46:69-81, 2000
29. Smalley W, Ray WA, Daugherty J, Griffin MR: Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: A population-based study. Arch Intern Med 159:161-166, 1999
30. Sonoshita M, Takaku K, Sasaki N, et al: Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Nat Med 7:1048-1051, 2001
31. Takafuji V, Lublin D, Lynch K, Roche JK: Mucosal prostanoid receptors and synthesis in familial adenomatous polyposis. Histochem Cell Biol 116:171-181, 2001
32. Takafuji VA, Evans A, Lynch KR, Roche JK: PGE(2) receptors and synthesis in human gastric mucosa: Perturbation in cancer. Prostaglandins Leukot Essent Fatty Acids 66:71-81, 2002
33. Tang X, Kim AL, Feith DJ, et al: Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1 +/- mice. J Clin Invest 113:867-875, 2004
34. Tiano HF, Loftin CD, Akunda J, et al: Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res 62:3395-3401, 2002